Interim seasonal influenza vaccine effectiveness estimates as proxy for final estimates: analysis of systematically identified matched pairs of interim/final estimates from test-negative design studies in outpatient settings from 2010/11 to 2018/19

References

• Boni MF. Vaccination and antigenic drift in influenza. Vaccine. 2008 Jul ; 18(26):C8–C14.
   Google Scholar
• Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013 Apr 19; 31(17):2165–2168.
   PubMed Web of Science ®Google Scholar
• Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ. Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness. Am J Epidemiol. 2016 Sep 1; 184(5):345–353.
   PubMed Web of Science ®Google Scholar
• World Health Organization.A description of the process of seasonal and H5N1 influenza vaccine virus selection and development. Geneva: The World Health Organization;2007.
   Google Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2019-2020 northern hemisphere influenza season;2019.
   Google Scholar
• Sullivan SG, Kelly H. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. Eurosurveillance. 2013 Oct 10;18(41):5–11.
   Web of Science ®Google Scholar
• Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine. 2011 Sep 2 29;(38)6558–6563.
   PubMed Web of Science ®Google Scholar
• Jimenez-Jorge S, Pozo F, Larrauri A, et al. Interim influenza vaccine effectiveness: a good proxy for final estimates in Spain in the seasons 2010-2014. Vaccine. 2015 Jun 26;33(29):3276–3280.
   PubMed Web of Science ®Google Scholar
• Leung VK, Cowling BJ, Feng S, et al. Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review. Euro Surveill. 2016 Apr 21;21(16):16.
   Google Scholar
• Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. [2019 Oct];3(10):ED000142.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21 6;(7)e1000097.
   PubMed Web of Science ®Google Scholar
• McGowan J, Sampson M, Salzwedel DM, et al. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016 Jul;75:40–46.
   PubMed Web of Science ®Google Scholar
• Okoli GN, Racovitan F, Righolt CH, et al. Variations in seasonal influenza vaccine effectiveness due to study characteristics: a systematic review and meta-analysis of test-negative design studies. Open Forum Infect Dis. 2020;7(7):ofaa177..
   PubMed Web of Science ®Google Scholar
• Okoli GN, Racovitan F, Abdulwahid T, et al. Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: a systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic. Vaccine. 2021 Feb 22 39;(8)1225–1240.
   PubMed Web of Science ®Google Scholar
• McHugh ML. The chi-square test of independence. Biochem Med (Zagreb). 2013;23(2):143–149.
   PubMed Web of Science ®Google Scholar
• Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009 Jul; 20(4):488–495.
   PubMed Web of Science ®Google Scholar
• Kissling E, Valenciano M, Cohen JM, et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One. 2011;6(11):e27622..
   PubMed Web of Science ®Google Scholar
• Kissling E, Valenciano M. I-MOVE case–control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: i-MOVE, a multicenter case–control study. Euro Surveill. 2011;16(11):19818. ii=..
   PubMedGoogle Scholar
• Pebody R, Hardelid P, Fleming DM, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Eurosurveillance. [2011 Feb 10];16(6):8–13.
   Web of Science ®Google Scholar
• Savulescu C, Jimenez-Jorge S, De Mateo S, et al. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Eurosurveillance. 2011 Mar 17 16;(11)5–10.
   Web of Science ®Google Scholar
• Jimenez-Jorge S, De Mateo S, Pozo F, et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Eurosurveillance. [2012–1 Mar 22];17(12):8–13.
   Web of Science ®Google Scholar
• Jimenez-Jorge S, Savulescu C, Pozo F, et al. Effectiveness of the 2010–11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine. 2012-2 May 21 30;(24)3595–3602.
   PubMed Web of Science ®Google Scholar
• Kissling E, Valenciano M. I-MOVE case–control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicenter case–control study, 2011/12. Euro Surveill. 2012;17(15): 20146. pii=.
   PubMedGoogle Scholar
• Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Eurosurveillance. 2013 Feb 14 18;(5)6–11.
   Web of Science ®Google Scholar
• Jackson L, Jackson ML, Phillips CH, et al. Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness - United States, February 2013. Mmwr-Morbid Mortal W. 2013 Feb 22;62(7):119–123.
   PubMed Web of Science ®Google Scholar
• Jimenez-Jorge S, De Mateo S, Delgado-Sanz C, et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. Bmc Infect Dis. 2013 Sep 22;13:13..
   PubMed Web of Science ®Google Scholar
• Kissling E, Larrauri A, Oroszi B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicenter case–control study. Euro Surveill. 2013;18(5):20390. pii=..
   PubMedGoogle Scholar
• Pebody RG, Andrews N, Fleming DM, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect. 2013 Mar 141;(3)620–630.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada’s sentinel surveillance network, January 2013. Eurosurveillance. 2013 Jan 31 18;(5)7–16.
   Web of Science ®Google Scholar
• Valenciano M, Kissling E, Team I-M-C-CS. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-move multicentre case-control study, 2012/13. Eurosurveillance. 2013 Feb 14;18(7):12–17.
   Web of Science ®Google Scholar
• Andrews N, McMenamin J, Durnall H, et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Eurosurveillance. 2014 Jul 10 19;(27)5–13.
   Web of Science ®Google Scholar
• Jimenez-Jorge S, Pozo F, De Mateo S, et al. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Eurosurveillance. 2014 Mar 6 19;(9)7–15.
   Web of Science ®Google Scholar
• Kissling E, Valenciano M, Buchholz U, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Eurosurveillance. 2014 Feb 13 19;(6)22–33.
   Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1) pdm09 from Canada’s sentinel surveillance network, January 2014. Eurosurveillance. 2014 Feb 6 19;(5)4–17.
   Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One. 2014;9(3):e92153..
   PubMed Web of Science ®Google Scholar
• Turner N, Pierse N, Huang QS, et al. Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. Eurosurveillance. [2014 Oct 23];19(42):19–24.
   Web of Science ®Google Scholar
• Flannery B, Clippard J, Zimmerman RK, et al. Early Estimates of Seasonal Influenza Vaccine Effectiveness - United States, January 2015. Mmwr-Morbid Mortal W. 2015 Jan 16;64(1):10–15.
   PubMed Web of Science ®Google Scholar
• Martinez-Baz I, Navascues A, Pozo F, et al. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Hum Vaccin Immunother. 2015;11(7):1626–1633..
   PubMed Web of Science ®Google Scholar
• McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis. [2015 May 15];211(10):1529–1540.
   PubMed Web of Science ®Google Scholar
• Pebody R, Warburton F, Andrews N, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveill. 2015;20:36.
   Google Scholar
• Pebody RG, Warburton F, Ellis J, et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Eurosurveillance. [2015 Feb 5];20(5):6–12.
   Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015. Eurosurveillance. 2015 Jan 29 20;(4)7–24.
   Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, et al. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. J Infect Dis. 2015 Sep 1 212;(5)726–739.
   PubMed Web of Science ®Google Scholar
• Chambers C, Skowronski DM, Sabaiduc S, et al. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. Euro Surveill. 2016;21(11):30168..
   PubMedGoogle Scholar
• Gherasim A, Pozo F, De Mateo S, et al. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15. Vaccine. 2016 Apr 29 34;(20)2371–2377.
   PubMed Web of Science ®Google Scholar
• Kissling E, Valenciano M. Early influenza vaccine effectiveness results 2015-16: i-MOVE multicentre case-control study. Euro Surveill. 2016;21(6):6.
   PubMedGoogle Scholar
• Pebody R, Warburton F, Ellis J, et al. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Euro Surveill. 2016 Sep 22;21:38.
   Google Scholar
• Pebody R, Warburton F, Ellis J, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results. Eurosurveillance. [2016 Mar 31];21(13):31–38.
   Web of Science ®Google Scholar
• Pierse N, Kelly H, Thompson MG, et al. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014. Vaccine. 2016 Jan 20 34;(4)503–509.
   PubMed Web of Science ®Google Scholar
• Redlberger-Fritz M, Kundi M, Detailed P-KT. Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria’s Sentinel Physician Surveillance Network. PLoS One. 2016;11(3):e0149916.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, et al. A Perfect Storm: impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season. Clin Infect Dis. 2016 Jul 1 63;(1)21–32.
   PubMed Web of Science ®Google Scholar
• Zimmerman RK, Nowalk MP, Chung J, et al. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. Clin Infect Dis. 2016 Dec 15 63;(12)1564–1573.
   PubMed Web of Science ®Google Scholar
• Flannery B, Chung JR, Thaker SN, et al. Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. Mmwr-Morbid Mortal W. 2017 Feb 17; 666:167–171.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, et al. Beyond Antigenic Match: possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada. J Infect Dis. 2017 Dec 19 216;(12)1487–1500.
   PubMed Web of Science ®Google Scholar
• Castilla J, Navascues A, Casado I, et al. Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18. Eurosurveillance. 2018 Feb 15 23;(7)2–7.
   Web of Science ®Google Scholar
• Flannery B, Chung JR, Belongia EA, et al. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. Mmwr-Morbid Mortal W. 2018 Feb 16; 676:180–185.
   PubMed Web of Science ®Google Scholar
• Kissling E, Valenciano M, Pozo F, et al. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children. Influenza Other Respir Viruses. 2018 Jul 12;(4)423–437.
   PubMed Web of Science ®Google Scholar
• Rondy M, Kissling E, Emborg HD, et al. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Euro Surveill. 2018 Mar;23:9..
   Google Scholar
• Doyle JD, Chung JR, Kim SS, et al. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019. Mmwr-Morbid Mortal W. 2019 Feb 15; 686:135–139.
   PubMed Web of Science ®Google Scholar
• Flannery B, Chung JR, Monto AS, et al. Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season. Clin Infect Dis. 2019 May 17 68;(11)1798–1806.
   PubMed Web of Science ®Google Scholar
• Kissling E, Pozo F, Buda S, et al. Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18). Vaccine X. 2019 Dec 10;3:100042.
   PubMedGoogle Scholar
• Martinez-Baz I, Navascues A, Casado I, et al. Remaining Effect of Influenza Vaccines Received in Prior Seasons. J Infect Dis. 2019 Aug 30 220;(7)1136–1140.
   PubMed Web of Science ®Google Scholar
• Pebody R, Djennad A, Ellis J, et al. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18. Euro Surveill. 2019 Aug 24;(31)31.
   Google Scholar
• Rolfes MA, Flannery B, Chung JR, et al. Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season. Clin Infect Dis. 2019 Nov 13 69;(11)1845–1853.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Leir S, Sabaiduc S, et al. Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Euro Surveill. 2019 Jan 24;(4)4.
   Google Scholar
• Skowronski DM, Sabaiduc S, Leir S, et al. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV). Euro Surveill. 2019 Nov 24;(46)46.
   Google Scholar
• Flannery B, Kondor RJG, Chung JR, et al. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season. J Infect Dis. 2020 Jan 1 221;(1)8–15.
   PubMed Web of Science ®Google Scholar